Virologist Karen Mossman and Fitzhenry Vector Lab director Brian Lichty will talk with MPs about the need to fill the made-in-Canada gap in vaccine development, and scaling up production.
The Robert E. Fitzhenry Vector Laboratory is the first facility of its kind in Canada and one of a few with the capacity to develop and produce viral-vectored vaccines for clinical testing.
The day-long event outlined the journey from academic discovery to commercial development, highlighting recent startup successes at McMaster